Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medpace Holdings, Inc.MEDP · Entity 3327 | Director | May 15, 2026 | May 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medpace Holdings, Inc.
Report date May 15, 2026 · Filed May 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $415.27 · Expires 2033-05-15 | Direct | 1,110 |
Reported balance
After 2026-05-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-15 · Grant · Acquired 1,110 · Balance 1,110 F1: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 18, 2026 17:30 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 1,110 | $0.00 Strike: $415.27 | $0.00 |
DisclosureSEC source: 0002029265-26-000002 · wk-form4_1779139812.xml · derivative · entry 1 Zander Dani S. · CIK 0002029265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,110 Underlying: Common Stock · 1,110 shares Expires 2033-05-15 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| May 16, 2025 Filed May 20, 2025 16:59 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 1,224 | $0.00 Strike: $305.66 | $0.00 |
DisclosureSEC source: 0001668397-25-000073 · wk-form4_1747774749.xml · derivative · entry 1 Zander Dani S. · CIK 0002029265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,224 Underlying: Common Stock · 1,224 shares Expires 2032-05-16 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 17:09 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 824 | $0.00 Strike: $407.24 | $0.00 |
DisclosureSEC source: 0001668397-24-000134 · wk-form4_1720040959.xml · derivative · entry 1 Zander Dani S. · CIK 0002029265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 824 Underlying: Common Stock · 824 shares Expires 2031-07-01 F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.